Position in VYGR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$404,736
-$2,604 QoQ
Shares Held
104,854
+1.2% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPTRUST FINANCIAL ADVISORS holds $130,226,430 across 94 Biotechnology names. VYGR ranks #36 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,502 | $29,748,185 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32,092 | $14,330,361 | |
| 3 | EXEL |
Exelixis, Inc.
|
312,296 | $13,394,375 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
121,088 | $7,825,917 | |
| 5 | CELC |
Celcuity Inc.
|
61,068 | $6,970,301 | |
| 6 | RPRX |
Royalty Pharma plc
|
143,760 | $6,896,167 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
29,900 | $5,969,535 | |
| 8 | INCY |
Incyte Corp
|
53,555 | $5,040,596 |
All Filings in VYGR
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $404,736 | 104,854 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $407,340 | 103,649 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $483,657 | 103,567 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $323,337 | 103,967 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $357,232 | 105,690 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $730,063 | 128,759 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $751,409 | 128,446 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,019,923 | 128,941 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,201,017 | 129,003 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $212,274 | 25,151 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $170,500 | 22,000 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $251,900 | 22,000 | Shares | Sole | 2023-08-15 | |
| No filing history on record for this holder in this stock. | ||||||